2024 - PR Telemedicine Technologies wins BSMA Clinical Trials Supply Chain Award for groundbreaking CleanWeb™-RTSM module - PR Revenues 2023 2023 - PR VisionHM listed at UGAP - PR acquisition of the French start-up CTMA - PR FY2023 Q1 results - PR FY2023 Q2 results - PR TTSA joins 40-Partner Consortium in xShare Initiative 2022 - PR acquisition of the Swiss company DAPSYS - PR BSA AIR - PR new facilities in Laval, France - PR new facilities in Liège, Belgium - PR FY2022 results 2021 - PR acquisition of the Belgian eCRO Lambda-Plus - PR VisionHM listed at UniHA
Contact
Investors relation
Telemedicine Technologies is the publisher of e-Health solutions, market leader in the field of Clinical Research with its CleanWeb™ solution, a secure Internet platform dedicated to the electronic management of clinical trials and registries.
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
December 19, 2024
2-4 February 2025 – Copenhagen | Booth 21 We’re thrilled to showcase CleanWeb™, our advanced eClinical Suite for managing Clinical Trials, Registries, and Managed Access Programs. With 20+ integrated modules, CleanWeb™ simplifies research and drives innovation. Meet our team and discover how we can support your upcoming clinical projects. Alongside our CRO Alliance partners (CERC, […]
December 19, 2024
Trial Site News The United Kingdom (UK) government has announced a £100 million public-private investment to establish 20 research/trial site hubs across the country, a move aimed at bolstering clinical trials and advancing treatment access. This initiative, part of the Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) Investment Programme, is a collaboration between the […]
December 19, 2024
Med City News LLMs bring great potential to help the healthcare industry center care around patients’ needs by improving communication, access, and engagement. However, LLMs also present significant challenges associated with privacy and bias that also must be considered. Large language models (LLMs) have generated buzz in the medical industry for their ability to pass […]